Skip to main content
    T

    Tonix Pharmaceuticals Holding Corp (TNXP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.94
    +0.06 (+2.08%)

    Market Cap: $58.49M

    Last updated: Nov 17, 2026 at 4:28 PM ET

    Tonix Pharmaceuticals Holding Corp (TNXP) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Tonix Pharmaceuticals Holding (TNXP) has a latest price of $2.94 on Nov 17, 2026, 85.7% below its 52-week high of $20.56. Its price fell 81.5% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 83.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $346,066,526.96 in Jan 2017 and its lowest $5.10 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TNXP with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TNXP.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 76.9%, and over 6 months it fell 78.6%. The month-end price fell 99.7% over the 3 years through Oct 2026, a compound annual decline of 86.1%.

    PeriodChange
    1 month-48.7%
    3 months-76.9%
    6 months-78.6%
    12 months-81.5%
    12 months, with dividends-81.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-99.7%-86.1%
    5 years-100.0%-89.2%
    10 years-100.0%-83.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price fell 26.6%, and its weakest was 2024, when it fell 97.4%.

    YearCloseChange
    2026 through Oct 2026$5.10-67.3%
    2025$15.62-52.6%
    2024$32.98-97.4%
    2023$1,291.67-83.5%
    2022$7,808.49-96.6%
    2021$229,662.33-47.0%
    2020$433,385.72-42.3%
    2019$751,201.92-94.7%
    2018$14,125,164.37-93.6%
    2017$221,508,259.37-26.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 59.8% below its 50-day average of $7.31 and 74.8% below its 200-day average of $11.65.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.94
    52-week high$20.56-85.7%
    52-week low$2.81+4.6%
    50-day average$7.31-59.8%
    200-day average$11.65-74.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.9%.

    MeasureValue
    1-year beta1.65
    Largest fall, 1 year-85.5%
    Largest fall, 3 years-99.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TNXP

    What is TNXP's 1-year price change?

    Tonix Pharmaceuticals Holding's price fell 81.5% over the past 12 months. With dividends included, the 12-month total return was -81.5%.

    What is TNXP's 5-year price change?

    Tonix Pharmaceuticals Holding's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 89.2%. These figures leave out dividends.

    What is TNXP's 52-week high and low?

    Tonix Pharmaceuticals Holding's 52-week high is $20.56 and its 52-week low is $2.81. Its latest price of $2.94 on Nov 17, 2026 is 85.7% below the high.

    What is TNXP's beta?

    Tonix Pharmaceuticals Holding's 1-year beta against the S&P 500 is 1.65, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 85.5%.

    Is the TNXP chart free?

    Yes. Advanced Charting for TNXP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.